When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling

Oral pre-exposure prophylaxis (PrEP) using the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) has been shown to dramatically reduce the risk of HIV acquisition for women at higher risk of infection if taken daily. Understanding when and why women would intentionally stop u...

Full description

Saved in:
Bibliographic Details
Published in:Cult Health Sex
Main Authors: Namey, Emily, Agot, Kawango, Ahmed, Khatija, Odhiambo, Jacob, Skhosana, Joseph, Guest, Greg, Corneli, Amy
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5049692/
https://ncbi.nlm.nih.gov/pubmed/27093238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13691058.2016.1164899
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items